Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...

Chief Financial Officer Nick Keher outlined the company’s progress in expanding beyond its historically research-led revenue base, highlighting rapid growth in clinical and applied industrial end ...

Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and opened entirely new doors in medicine. From vaccines to mRNA technology, ...

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

Researchers have found a way to detect persistent Epstein-Barr virus directly from routine blood-based genome sequencing, bypassing the antibody tests that have defined EBV diagnostics for decades.